Share Email Print

Proceedings Paper

The application of 5-aminolevulinic acid in the treatment of precancerous lesions, skin cancer, and a new approach to the control of therapy
Author(s): Zbigniew Kulas; Elżbieta Bereś - Pawlik; Andrzej Bieniek; Łukasz Matusiak
Format Member Price Non-Member Price
PDF $17.00 $21.00

Paper Abstract

The aim of our work was to determine a therapeutic effect of photodynamic therapy (PDT). Twenty five patients with the Bowen's disease, actinic keratosis and basal cell carcinoma (superficial, nodular) were examined. They were treated with photosensitizer - aminolevulinic acid (metabolized in protoporphyrin IX), and the new red light source built of high-power diodes. A new method, based on numerical analysis of fluorescence imaging of tissues, was proposed as a way for controlling therapy.

Paper Details

Date Published: 23 February 2009
PDF: 7 pages
Proc. SPIE 7161, Photonic Therapeutics and Diagnostics V, 716111 (23 February 2009); doi: 10.1117/12.809611
Show Author Affiliations
Zbigniew Kulas, Wroclaw Univ. of Technology (Poland)
Elżbieta Bereś - Pawlik, Wroclaw Univ. of Technology (Poland)
Andrzej Bieniek, Wroclaw Medical Univ. (Poland)
Łukasz Matusiak, Wroclaw Medical Univ. (Poland)

Published in SPIE Proceedings Vol. 7161:
Photonic Therapeutics and Diagnostics V
Henry Hirschberg M.D.; Brian Jet-Fei Wong M.D.; Kenton W. Gregory M.D.; Reza S. Malek; Nikiforos Kollias; Bernard Choi; Guillermo J. Tearney; Justus F. R. Ilgner; Steen J. Madsen; Laura Marcu; Haishan Zeng, Editor(s)

© SPIE. Terms of Use
Back to Top